AIM ImmunoTech Inc has a consensus price target of $3 based on the ratings of 2 analysts. The high is $5 issued by Ascendiant Capital on September 3, 2024. The low is $1 issued by Maxim Group on October 22, 2024. The 2 most-recent analyst ratings were released by Maxim Group and Ascendiant Capital on October 22, 2024 and September 3, 2024, respectively. With an average price target of $3 between Maxim Group and Ascendiant Capital, there's an implied 1317.10% upside for AIM ImmunoTech Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for AIM ImmunoTech (AMEX:AIM) was reported by Maxim Group on October 22, 2024. The analyst firm set a price target for $1.00 expecting AIM to rise to within 12 months (a possible 372.37% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for AIM ImmunoTech (AMEX:AIM) was provided by Maxim Group, and AIM ImmunoTech maintained their buy rating.
There is no last upgrade for AIM ImmunoTech
There is no last downgrade for AIM ImmunoTech.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AIM ImmunoTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AIM ImmunoTech was filed on October 22, 2024 so you should expect the next rating to be made available sometime around October 22, 2025.
While ratings are subjective and will change, the latest AIM ImmunoTech (AIM) rating was a maintained with a price target of $2.00 to $1.00. The current price AIM ImmunoTech (AIM) is trading at is $0.21, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.